Akzo Nobel's announcement that it will buy Hoechst Roussel Vet, the veterinary business of Hoechst AG, for EUR 665 million, roughly doubling its own animal-health unit Intervet.
Akzo Nobel has agreed to acquire Hoechst Roussel Vet, the veterinary business of Hoechst AG for EUR 665 million. The acquisition effectively doubles the size of Akzo Nobel's Intervet business, with combined sales of both operations in 1998 totaling approximately EUR 800 million.
Akzo Nobel's announcement that it will buy Hoechst Roussel Vet, the veterinary business of Hoechst AG, for EUR 665 million, roughly doubling its own animal-health unit Intervet. Neutral corporate disclosure: acquiring company Akzo Nobel N.V. (Arnhem, Netherlands); target Hoechst Roussel Vet, the veterinary business of Hoechst AG (Germany); consideration EUR 665 million; 2,400 employees and all production and R&D facilities included; target's 1998 sales EUR 450 million. Company press release, not a study. Company website version at akzonobel.com/for-media/media-releases-and-features/akzo-nobel-reinforces-its-pharma-group-acquisition-hoechst. Context: first documented link in the ownership chain that ends with Merck Animal Health. Study type: news.
